Search

everythinglearnresearchcommunity

for

Search:↓

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

African spiny mice can regenerate skin, hair, and cartilage, but not muscle, and their unique abilities could be useful for regenerative medicine.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

Some breast cancer chemotherapy can cause permanent hair loss.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Smad-4 and Smad-7 are key in hair follicle development, with other Smads being less important.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.